BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28819285)

  • 61. BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.
    Chu S; Li L; Singh H; Bhatia R
    Cancer Res; 2007 Jul; 67(14):7045-53. PubMed ID: 17638918
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway.
    Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL
    Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations.
    Naito H; Kimura S; Nakaya Y; Naruoka H; Kimura S; Ito S; Wakayama T; Maekawa T; Hirabayashi K
    Leuk Res; 2006 Nov; 30(11):1443-6. PubMed ID: 16546254
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats.
    Frank DA; Varticovski L
    Leukemia; 1996 Nov; 10(11):1724-30. PubMed ID: 8892675
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vav2 as a Rac-GDP/GTP exchange factor responsible for the nectin-induced, c-Src- and Cdc42-mediated activation of Rac.
    Kawakatsu T; Ogita H; Fukuhara T; Fukuyama T; Minami Y; Shimizu K; Takai Y
    J Biol Chem; 2005 Feb; 280(6):4940-7. PubMed ID: 15485841
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice.
    Hu T; Chong Y; Lu S; Qin H; Ren M; Savage NM; Chang CS; Cowell JK
    Cancer Res; 2019 Jan; 79(1):114-124. PubMed ID: 30413411
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine.
    Scita G; Tenca P; Areces LB; Tocchetti A; Frittoli E; Giardina G; Ponzanelli I; Sini P; Innocenti M; Di Fiore PP
    J Cell Biol; 2001 Sep; 154(5):1031-44. PubMed ID: 11524436
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl.
    Harnois T; Constantin B; Rioux A; Grenioux E; Kitzis A; Bourmeyster N
    Oncogene; 2003 Sep; 22(41):6445-54. PubMed ID: 14508524
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Wasik M; Trotta R; Kanakaraj P; Salomoni P; Antonyak M; Martinez R; Majewski M; Wong A; Perussia B; Calabretta B
    Blood; 1998 Jan; 91(2):406-18. PubMed ID: 9427693
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PREX1 Protein Function Is Negatively Regulated Downstream of Receptor Tyrosine Kinase Activation by p21-activated Kinases (PAKs).
    Barrows D; He JZ; Parsons R
    J Biol Chem; 2016 Sep; 291(38):20042-54. PubMed ID: 27481946
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interaction of Abl Tyrosine Kinases with SOCS3 Impairs Its Suppressor Function in Tumorigenesis.
    Feng R; Wang X; Li J; Chen K; Guo G; Liao Y; Sun L; Huang S; Chen JL
    Neoplasia; 2018 Nov; 20(11):1095-1105. PubMed ID: 30236924
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
    Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
    Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
    Nieborowska-Skorska M; Slupianek A; Skorski T
    Oncogene; 2000 Aug; 19(36):4117-24. PubMed ID: 10962572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Collagen phagocytosis is regulated by the guanine nucleotide exchange factor Vav2.
    Arora PD; Marignani PA; McCulloch CA
    Am J Physiol Cell Physiol; 2008 Jul; 295(1):C130-7. PubMed ID: 18434624
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy.
    Gross AW; Zhang X; Ren R
    Mol Cell Biol; 1999 Oct; 19(10):6918-28. PubMed ID: 10490629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of ephexin1, a guanine nucleotide exchange factor of Rho family GTPases, by fibroblast growth factor receptor-mediated tyrosine phosphorylation.
    Zhang Y; Sawada T; Jing X; Yokote H; Yan X; Sakaguchi K
    J Biol Chem; 2007 Oct; 282(42):31103-12. PubMed ID: 17702745
    [TBL] [Abstract][Full Text] [Related]  

  • 78. SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl.
    Chen J; Yu WM; Daino H; Broxmeyer HE; Druker BJ; Qu CK
    Blood; 2007 Jan; 109(2):778-85. PubMed ID: 17003374
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding.
    Das B; Shu X; Day GJ; Han J; Krishna UM; Falck JR; Broek D
    J Biol Chem; 2000 May; 275(20):15074-81. PubMed ID: 10748082
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.
    Pendergast AM; Gishizky ML; Havlik MH; Witte ON
    Mol Cell Biol; 1993 Mar; 13(3):1728-36. PubMed ID: 8441409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.